To develop a mouse model of SWS/SWA enhancement in AD, we crossed the APP/PS1 mouse line to Vgat::GFP mice, resulting in a quadruple transgenic mouse model (APP/PS1/Vgat::GFP; hereafter AP+). The gene discussed is APP; the disease is Alzheimer disease.